771
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice

, , , , , , , , , , , & show all
Pages 1990-1994 | Received 12 Nov 2020, Accepted 20 Feb 2021, Published online: 07 Mar 2021
 

Author contributions

B.L.M., M.P.P, and C.K. were responsible for conception and design; B.L.M, M.P.P, M.H., and B.W. were responsible for development of methodology and acquisition of data; B.L.M., K.R., A.F., M.J.H., H.R., and C.K. were responsible for analysis and interpretation of data; K.R., A.F., and H.R. were responsible for drafting the manuscript; all authors were involved with review and/or revision of the manuscript; and B.L.M. was responsible for overall study supervision.

Disclosure statement

The authors declare no competing financial interests.

Additional information

Funding

This study was funded with a grant awarded by the Hematology/Oncology Pharmacy Association (HOPA). Research reported in this publication was supported by the National Cancer Institutes of Health under Award Number P30CA046592 by the use of the following Cancer Center Shared Resource(s): Pharmacokinetics Core.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.